Essential Characteristics PED testing_NSW.docx
DOCX document 15 KB Posted
- Solicitation number
- 1301242246
About this file
The document is an Essential Characteristics file for Performance Enhancing Drug (PED) Testing for the Department of Defense (DOD) Drug Demand Reduction Program (DDRP). The requirement is for a World Anti-Doping Agency (WADA) accredited laboratory to provide urinalysis testing for substances listed on the Office of the Under Secretary of Defense Special Drug Testing Panel, with an annual capacity of up to 19,000 initial PED tests and 1,140 Isotope Ratio Mass Spectrometry (IRMS) tests.
Key specifications include the ability to test specimen batches up to 350 specimens, provide telephonic result discussions for 40 hours annually, and implement a priority testing procedure with test results reported within 7-10 business days. The contract is for a performance period of up to five years, targeting the Navy Drug Demand Reduction Program. The testing must comply with DOD instructions, WADA guidelines, and adhere to the Designer Anabolic Steroid Control Act of 2014, with the Department of the Navy Naval Supply Systems Command serving as the contracting agency.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| PWS - DDRP PED Testing.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
ESSENTIAL CHARACTERISTICS
Performance Enhancing Drug Testing for Priority testing
The Department of Defense (DOD) Drug Demand Reduction Program (DDRP) has a requirement for a World Anti-Doping Agency (WADA) accredited, performance enhancing drug testing laboratory. The laboratory shall provide urinalysis testing for all substances listed on the Office of the Under Secretary of Defense Memorandum “Department of Defense Special Drug Testing Panel,” April 24, 2024. Proposals shall comply with the Performance Work Statement (PWS).
The specimen testing is required for a period of performance of up to five (5) years. The estimated number of tests shall accommodate annually up to 19,000 initial tests for performance enhancing drugs (PED). In addition to PED tests, this shall also include up to 1,140 Isotope Ratio Mass Spectrometry (IRMS) tests. The vendor shall be able to test specimens in batches, not to exceed three hundred and fifty (350) specimens. The vendor shall be able to provide telephonic discussion of results for up to forty (40) hours per year. The vendor shall be able to provide a priority testing procedure to accommodate turnaround time requirements of the government. This shall include priority testing procedure with report results being reported within 7 business days on average, but not to exceed 10 business days.
File details come from the government source that posted it. Updated .